Unknown

Dataset Information

0

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.


ABSTRACT: During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online "immuno-analytics" resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid proteins are both vaccine and serological diagnostic targets. Using the tool, the nucleocapsid protein appears to be a sub-optimal target for use in serological platforms. Spike D614G (and nsp12 L314P) mutations were most frequent (> 86%), whilst spike A222V/L18F have recently increased. Also, Orf3a proteins may be a suitable target for serology. The tool can accessed from: http://genomics.lshtm.ac.uk/immuno (online); https://github.com/dan-ward-bio/COVID-immunoanalytics (source code).

SUBMITTER: Ward D 

PROVIDER: S-EPMC7790334 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8734241 | biostudies-literature
2024-03-20 | GSE236747 | GEO
| S-EPMC6614803 | biostudies-literature
| S-EPMC5493659 | biostudies-literature
| S-EPMC6167368 | biostudies-literature
2016-02-19 | E-GEOD-66092 | biostudies-arrayexpress
| S-EPMC9228227 | biostudies-literature
| S-EPMC5025611 | biostudies-literature
| S-EPMC4658549 | biostudies-literature
| S-EPMC7111504 | biostudies-literature